# FDA WARNING_LETTER - EyePoint Pharmaceuticals, Inc. - February 15, 2024

Source: https://www.globalkeysolutions.net/records/warning_letter/eyepoint-pharmaceuticals-inc/e379cc88-9b93-49f9-897d-71e0ceb96159

> FDA WARNING_LETTER for EyePoint Pharmaceuticals, Inc. on February 15, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: EyePoint Pharmaceuticals, Inc.
- Inspection Date: 2024-02-15
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations Division I

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/eyepoint-pharmaceuticals-inc/3244db57-9043-4e9c-aefe-d1732dd5376b)

## Related Officers

- [Samina S. Khan](https://www.globalkeysolutions.net/people/samina-s-khan/ca3e266c-aa69-4c28-9901-d344e0c259fd)
- [Program Division Director](https://www.globalkeysolutions.net/people/lisa-m-harlan/e5d04349-6dd6-4f08-b31f-bf719c8413ab)

Company: https://www.globalkeysolutions.net/companies/eyepoint-pharmaceuticals-inc/ca6562a2-b315-4e33-b9b2-394c1c8ad945

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations-division-i/798d6a62-d1f1-4f7c-8de3-465e277c13da